View source for CR:DOI:fa5a924ce400bc9f7a71b219c95b68c2

{{#scite:
 |reference=ng2018lo
 |type=article-journal
 |title=Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting
 |author=Siew C Ng;Ida Normiha Hilmi;Aimee Blake;Fatima Bhayat;Shashi Adsul;Qasim Rana Khan;Deng-Chyang Wu|+sep=;
 |journal=Inflammatory Bowel Diseases
 |publisher=Oxford University Press (OUP)
 |year=2018
 |volume=24
 |issue=11
 |pages=2431-2441
 |doi=10.1093/ibd/izy153
 |subject=Immunology and Allergy;Gastroenterology|+sep=;
 |issn=1078-0998;1536-4844|+sep=;
 |retrieved-from=https://dx.doi.org/
 |retrieved-on=2019-11-05
 |@show=true
}}